Unlock stock picks and a broker-level newsfeed that powers Wall Street.

SEHK Growth Companies With High Insider Ownership And Earnings Growth Up To 55%

In This Article:

Amid a backdrop of fluctuating global markets, Hong Kong's Hang Seng Index has recently shown resilience, climbing 2.64% as noted in recent updates. This positive momentum in the Hong Kong market sets an intriguing stage for examining growth companies with high insider ownership, which can be indicative of confidence from those closest to the company's operations and future prospects.

Top 10 Growth Companies With High Insider Ownership In Hong Kong

Name

Insider Ownership

Earnings Growth

New Horizon Health (SEHK:6606)

16.6%

61%

iDreamSky Technology Holdings (SEHK:1119)

20.1%

104.1%

Meitu (SEHK:1357)

38%

34.3%

Adicon Holdings (SEHK:9860)

22.3%

29.6%

DPC Dash (SEHK:1405)

38.2%

91.5%

Tian Tu Capital (SEHK:1973)

34%

70.5%

Zhejiang Leapmotor Technology (SEHK:9863)

14.2%

74%

Biocytogen Pharmaceuticals (Beijing) (SEHK:2315)

15.7%

100.1%

Ocumension Therapeutics (SEHK:1477)

17.7%

93.7%

Beijing Airdoc Technology (SEHK:2251)

26.4%

83.9%

Click here to see the full list of 52 stocks from our Fast Growing SEHK Companies With High Insider Ownership screener.

Below we spotlight a couple of our favorites from our exclusive screener.

LifeTech Scientific

Simply Wall St Growth Rating: ★★★★☆☆

Overview: LifeTech Scientific Corporation, an investment holding company, specializes in developing, manufacturing, and trading interventional medical devices for cardiovascular and peripheral vascular diseases globally, with a market capitalization of approximately HK$8.61 billion.

Operations: LifeTech Scientific's revenue is derived from three main segments: Structural Heart Diseases Business generating CN¥495.67 million, Peripheral Vascular Diseases Business contributing CN¥707.11 million, and Cardiac Pacing and Electrophysiology Business at CN¥64.40 million.

Insider Ownership: 17.4%

Earnings Growth Forecast: 20.5% p.a.

LifeTech Scientific, a growth company in Hong Kong with high insider ownership, is navigating through financial complexities with mixed results. While its revenue growth of 16.8% per year outpaces the local market's 8%, and earnings are expected to increase by 20.5% annually, recent financial statements show a decline in net income from CNY 325.34 million to CNY 263.24 million year-over-year due to non-recurring losses and increased expenses in share-based payments. Despite these challenges, no significant insider shares were purchased recently, reflecting potential caution among insiders about immediate growth prospects.